Literature DB >> 29580778

Two-Field Lymphadenectomy During Esophagectomy: The Presence of Thoracic Duct Lymph Nodes.

Bernadette Schurink1, Ingmar L Defize1, Elena Mazza2, Jelle P Ruurda2, Lodewijk A A Brosens3, Tom A P Roeling4, Ronald L A W Bleys4, Richard van Hillegersberg5.   

Abstract

BACKGROUND: Resection of the thoracic duct is part of the formal en bloc mediastinal esophagolymphadenectomy for cancer, although with the adaptation of minimally invasive techniques, some centers started to leave the thoracic duct compartment in situ. However, previous studies reported thoracic duct lymph nodes in this compartment that may contain metastasis. The aim of this study was to assess the presence and number of lymph nodes in the fatty tissue surrounding the thoracic duct.
METHODS: A right-sided thoracoscopic esophagectomy was performed on seven fresh-frozen human cadavers (male, n = 3; female, n = 4). The esophagus and lymph node stations 7, 8, and 9 were resected en bloc, followed by resection of the thoracic duct compartment consisting of the fatty tissue covering the aorta, the thoracic duct and thoracic duct lymph nodes. Lymph nodes were visualized by a hematoxylin and eosin stain and counted macroscopically and microscopically.
RESULTS: Thoracic duct lymph nodes were found in 6 of 7 cadavers (86%), with a median number of 1 (range, 0 to 6). Nodes were predominantly located in the area of the azygos vein. A median of 4 subcarinal nodes (range, 1 to 8) and 2 periesophageal nodes (range, 1 to 4) were present.
CONCLUSIONS: This study shows that thoracic duct lymph nodes are located within the fatty tissue surrounding the thoracic duct. Resection of this compartment during an esophagectomy for cancer increases lymph node yield.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29580778     DOI: 10.1016/j.athoracsur.2018.02.047

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy.

Authors:  I L Defize; S van der Horst; M Bülbul; N Haj Mohammad; S Mook; G J Meijer; L A A Brosens; J P Ruurda; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2020-12-19       Impact factor: 5.344

2.  Prognostic impact of thoracic duct lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Satoru Matsuda; Hirofumi Kawakubo; Hiroya Takeuchi; Shuhei Mayanagi; Tomoyuki Irino; Kazumasa Fukuda; Rieko Nakamura; Norihito Wada; Yuko Kitagawa
Journal:  Ann Gastroenterol Surg       Date:  2021-01-19

3.  The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.

Authors:  Jessica M Leers; Laura Knepper; Arjen van der Veen; Wolfgang Schröder; Hans Fuchs; Petra Schiller; Martin Hellmich; Ulrike Zettelmeyer; Lodewijk A A Brosens; Alexander Quaas; Jelle P Ruurda; Richard van Hillegersberg; Christiane J Bruns
Journal:  BMC Cancer       Date:  2020-08-20       Impact factor: 4.430

4.  An Unusual Cause of Chylothorax after Esophagectomy.

Authors:  John Mathew Manipadam; Chokkappu S Kumar; Rajesh Antony; Abhishek Yadav; H Ramesh
Journal:  Surg J (N Y)       Date:  2020-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.